This site is only for UK healthcare professionals and contains promotional information.

Prescribing Information can be found at the bottom of this page.

Georgia, 29

Suffers with moderate itch

  • Georgia

Georgia, 29

Profile

  • 29-year-old carpenter
  • Loves working with her hands but is unable to work full-time
  • Psoriasis affects her torso and scalp
  • Moderate VAS score of 65
  • Itching can be overwhelming and disrupts her work

Treatment goals

  • Reducing itching is her top priority so that she can work full-time

"I just want to get rid of the irritating itch caused by my psoriasis."

The benefits of ILUMETRI® for Georgia:

REDUCTION IN ITCHING1

EFFECTIVE IN SENSITIVE AREAS, INCLUDING SCALP1

IMPROVED QUALITY OF LIFE2

EFFECTIVE RELIEF OF SYMPTOMS1

PASI 75, 90 and 100 responses are well-maintained for up to 5 years of treatment with ILUMETRI®3

Suffers with moderate itch
Has signs of metabolic syndrome

You might also be interested in

ILUMETRI® itch patient profile
Download additional information about the benefits of ILUMETRI® for patients with moderate itch
Watch the video

Discover your reason to prescribe ILUMETRI®

German case report

An ILUMETRI® case report demonstrating results in the real world

PASI, Psoriasis Area Severity Index. VAS, visual analogue scale.
References
  1. Tsianakas A, et al. Interim analysis of the non-interventional study TILOT: effectiveness of tildrakizumab in long-term treatment of moderate to severe plaque psoriasis in routine practice. EADV Congress. 29–31 October 2020. Poster: P1336.
  2. Reich K, et al. Lancet 2017;390:276–288.
  3. Thaçi D, et al. Br J Dermatol 2021. DOI: 10.1111/bjd.19866.

UK-ILU-2100104 November 2021

My Favorites